Ambrx Biopharma Inc. American Depositary Shares (each representing seven) Soared
Mon, Jan 08, 2024 at 07:36 PM
Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE) soared at $27.47, representing a gain of 101.5%. On Mon, Jan 08, 2024, AMAM:NYSE touched a New 2-Week High of $27.47. The stock got featured on our News Catalysts scanner on Mon, Jan 08, 2024 at 03:52 PM in the 'BIOTECH' category. From Tue, Dec 26, 2023, the stock recorded 50.00% Up Days and 33.33% Green Days
About Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE)
Ambrx Biopharma Inc is a clinical-stage biologics company focused on discovering and developing a novel class of engineered precision biologics (EPBs) using its proprietary expanded genetic code...
Top 10 Gainers:
- Statera Biopharma Inc. (STAB:NASDAQ), 59900%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 141.94%
- Harpoon Therapeutics, Inc. (HARP:NASDAQ), 111.94%
- Elevation Oncology Inc. (ELEV:NASDAQ), 106.95%
- Ambrx Biopharma Inc. (AMAM:NASDAQ), 101.54%
- Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE), 101.54%
- Nkarta Inc. (NKTX:NASDAQ), 77.06%
- Kaspien Holdings Inc. (KSPN:NASDAQ), 63.64%
- Universe Pharmaceuticals Inc (UPC:NASDAQ), 46.15%
- Kiromic BioPharma Inc. (KRBP:NASDAQ), 45.83%